Skip to content
CancerIndex

Publication

Retrospective assessment of TCF12 expression in early invasive breast cancer and ovarian cancer: prognostic implications and biological insights.

Nuanphan Polchai, Denys Ndeke, Khalid Alshammari, Megan R Greener, Tangkam R Marak, Maisie Henman, Suha Deen, Andrew R Green, Ian O Ellis, Emad A Rakha, Stewart G Martin, Sarah J Storr

PathologyOct 1, 2026PMID 42552187doi:10.1016/j.pathol.2026.05.009 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Oct 1, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20261001-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Transcription factor 12 (TCF12) is a basic helix-loop-helix transcription factor implicated in tissue differentiation and pathogenesis in many types of cancer. Its role in breast and ovarian cancer remains poorly understood. TCF12 protein expression was assessed by immunohistochemistry in 1,514…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.